M Scheinin

Evidence that the reversible MAO-A inhibitor moclobemide increases prolactin secretion by a serotonergic mechanism in healthy male volunteers.

M. Koulu, M. Scheinin, M Scheinin, 1990, Life sciences.

Medetomidine--a novel alpha 2-adrenoceptor agonist: a review of its pharmacodynamic effects.

M. Scheinin, H. Scheinin, R. Lammintausta, 1989, Progress in neuro-psychopharmacology & biological psychiatry.

Follow-up of [11C]PIB uptake and brain volume in patients with Alzheimer disease and controls

J O Rinne, M. Viitanen, J. Lötjönen, 2009, Neurology.

Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from nonimpulsive violent behavior.

M Linnoila, F. Goodwin, M. Scheinin, 1983, Life sciences.

The second extracellular loop of α2A‐adrenoceptors contributes to the binding of yohimbine analogues

M. Scheinin, M. Johnson, M. Johnson, 2007, British journal of pharmacology.

CSF neurochemistry of women with anorexia nervosa and normal women.

B A Shaywitz, L Fairbanks, M Linnoila, 1984, The American journal of psychiatry.

An introduction to the pharmacology of alpha 2-adrenoceptors in the central nervous system.

M. Scheinin, M Scheinin, E. Macdonald, 1989, Acta veterinaria Scandinavica. Supplementum.

Distribution and pharmacology of alpha 2-adrenoceptors in the central nervous system.

M. Scheinin, M Scheinin, E. Macdonald, 1995, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.